Myrexis, Inc.
MYRX
$0.00
$0.00-94.00%
OTC PK
| 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -261.00K | -3.83M | -2.67M | -2.67M | -2.67M |
| Gross Profit | 261.00K | 3.83M | 2.67M | 2.67M | 2.67M |
| SG&A Expenses | 10.74M | 12.17M | 15.00M | 14.10M | 15.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.19M | 10.03M | 18.41M | 21.17M | 26.10M |
| Operating Income | -11.19M | -10.03M | -18.41M | -21.17M | -26.10M |
| Income Before Tax | -11.62M | -15.89M | -23.34M | -26.04M | -31.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.62 | -15.89 | -23.34 | -26.04 | -31.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.62M | -15.89M | -23.34M | -26.04M | -31.21M |
| EBIT | -11.19M | -10.03M | -18.41M | -21.17M | -26.10M |
| EBITDA | -10.81M | -9.36M | -17.43M | -20.01M | -24.82M |
| EPS Basic | -0.42 | -0.58 | -0.88 | -0.98 | -1.18 |
| Normalized Basic EPS | -0.25 | -0.22 | -0.43 | -0.49 | -0.61 |
| EPS Diluted | -0.42 | -0.58 | -0.88 | -0.98 | -1.18 |
| Normalized Diluted EPS | -0.25 | -0.22 | -0.43 | -0.49 | -0.61 |
| Average Basic Shares Outstanding | 118.08M | 110.35M | 106.94M | 106.27M | 105.55M |
| Average Diluted Shares Outstanding | 118.08M | 110.35M | 106.94M | 106.27M | 105.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |